Content about Stock market

ROCHESTER, N.Y. — Bausch + Lomb on Friday announced that it has filed a registration statement with the U.S. Securities and Exchange Commission to take the company public. The number of shares to be offered and the price range for the proposed offering have not yet been determined, the company stated. 

The proposed IPO could raise as much as $1.5 billion and is expected to value Bausch & Lomb at about $9 billion to $10 billion, Reuters reported earlier in March.

NEW YORK — Wall Street on Wednesday celebrated the "fiscal cliff" compromise as stocks across the board were trading up by some 200 basis points. As of noon, the Dow was up 1.7% and Nasdaq 2.3%. 

ASHEVILLE, N.C. — Ingles Markets announced that its board of directors has declared a quarterly cash dividend of 16.5 cents per share on all its class A common stock and 15 cents per share on all its class B common stock. This is an annual rate of 66 cents and 60 cents, respectively.

Both dividends are payable Oct. 25 to shareholders of record on Oct. 11.

WOONSOCKET, R.I. — CVS Caremark announced that its board of directors has approved a new share repurchase program for up to $6 billion of the company's outstanding common stock.
 
The share repurchase authorization, which is effective immediately, permits the company to effect the repurchases from time to time through a combination of open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.

NEW YORK — Coty has filed to raise as much as $700 million in an initial public offering. The filing with the Securities and Exchange Commission comes about a month after the beauty company dropped its bid for Avon because of Avon’s “delay and unwillingness to engage in discussions.”

In the filing, Coty told the SEC that it intends to list the Class A common stock on either the NASDAQ or the New York Stock Exchange under the symbol “COTY.” Coty did not reveal how many shares it plans to sell or their expected price.

CHESAPEAKE, Va. — Dollar Tree on Tuesday approved a 2-for-1 stock split in the form of a 100% common stock dividend. The new shares will be distributed June 26 for shareholders of record as of the close of business on June 12.

With the stock split, the number of outstanding shares of the company's common stock will increase from approximately 116 million shares, pre-split, to approximately 232 million shares, post-split.

NEW YORK — Pfizer is selling its nutrition business to Nestlé for $11.85 billion, Pfizer said Monday.

Pfizer Nutrition, which had sales of about $2.1 billion in 2011, manufactures and markets nutrition products for children, including baby and toddler formulas, follow-on formulas and maternal and adult nutrition products.

HAWTHORNE, N.Y. — Taro Pharmaceutical Industries will list its shares on the New York Stock Exchange, the Israel-based generic drug maker said Monday.

Starting Thursday, shares of Taro will trade on the exchange under the ticker symbol "TARO" and will concurrently cease to trade on the over-the-counter Pink Sheet markets.

WASHINgTON — A Consumer Healthcare Products Association study earlier this year supported what everyone has known all along: Use of over-the-counter medicines saves the U.S. healthcare system money. A lot of it. 


For every dollar spent on over-the-counter medicines, the U.S. healthcare system realizes a savings of between $6 and $7, or $102 billion all told, according to CHPA’s study, “The Value of OTC Medicine to the United States.”


SILVER SPRING, Md. — Ranbaxy Labs got the green light from the Food and Drug Administration Wednesday night to launch its generic version of Pfizer's cholesterol-lowering drug Lipitor.

The FDA announced the approval of Ranbaxy's atorvastatin calcium tablets in the 10-mg, 20-mg, 40-mg and 80-mg strengths. New Brunswick, N.J.-based Ohm Labs will manufacture the drug.

DEERFIELD, Ill. — The board of directors of Walgreens on Wednesday increased the quarterly dividend 28.6% — the largest quarterly dividend increase in the company's 110-year history — to 22.5 cents per share from the previous rate of 17.5 cents per share.

BENTONVILLE, Ark. — Walmart's board of directors has approved a new program authorizing the company to repurchase $15 billion of its shares, the company announced at its 41st annual meeting of shareholders Friday.

This program replaces the previous $15 billion program, announced on June 4, 2010, that had approximately $2 billion of remaining authorization. Under the program, repurchased shares are retired constructively and returned to unissued status.